Author

Manuel López-Vico

IMPACT OF INFLAMMATORY BOWEL DISEASE ON THE QUALITY OF LIFE OF PATIENT’S HOUSEHOLD MEMBERS
IMPACT OF INFLAMMATORY BOWEL DISEASE ON THE QUALITY OF LIFE OF PATIENT’S HOUSEHOLD MEMBERS

IMPACT OF INFLAMMATORY BOWEL DISEASE ON THE QUALITY OF LIFE OF PATIENT’S HOUSEHOLD MEMBERS
IMPACT OF INFLAMMATORY BOWEL DISEASE ON THE QUALITY OF LIFE OF PATIENT’S HOUSEHOLD MEMBERS

Manuel López-Vico  et al.

THE SHOCK INDEX IS NOT BETTER THAN PRE-EXISTING SCORING AT PREDICTING OUTCOMES IN UPPER GASTROINTESTINAL BLEEDING PATIENTS.
THE SHOCK INDEX IS NOT BETTER THAN PRE-EXISTING SCORING AT PREDICTING OUTCOMES IN UPPER GASTROINTESTINAL BLEEDING PATIENTS.

Manuel López-Vico  et al.

NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING IN PATIENTS WITHOUT AND WITH COMPENSATED AND DECOMPENSATED CIRRHOSIS: EPIDEMIOLOGY, OUTCOMES AND PREDICTIVE FACTORS OF MORTALITY
NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING IN PATIENTS WITHOUT AND WITH COMPENSATED AND DECOMPENSATED CIRRHOSIS: EPIDEMIOLOGY, OUTCOMES AND PREDICTIVE FACTORS OF MORTALITY

Manuel López-Vico  et al.

PREDICTIVE ABILITY OF AVAILABLE SCORES IN MASSIVE UPPER GASTROINTESTINAL BLEEDING
PREDICTIVE ABILITY OF AVAILABLE SCORES IN MASSIVE UPPER GASTROINTESTINAL BLEEDING

Manuel López-Vico  et al.

VEDOLIZUMAB IN REAL PRACTICE: EXPERIENCE IN A TERTIARY HOSPITAL
VEDOLIZUMAB IN REAL PRACTICE: EXPERIENCE IN A TERTIARY HOSPITAL

Manuel López-Vico  et al.

LIVER SPECIFIC SCORES AND GASTROINTESTINAL BLEEDING SCORING SYSTEMS TO PREDICT OUTCOMES IN PATIENTS WITH ACUTE UPPER GASTROINTESTINAL BLEEDING
LIVER SPECIFIC SCORES AND GASTROINTESTINAL BLEEDING SCORING SYSTEMS TO PREDICT OUTCOMES IN PATIENTS WITH ACUTE UPPER GASTROINTESTINAL BLEEDING

Manuel López-Vico  et al.

COMPARISSION OF THE NEW ABC SCORE AND MAP(ASH) SCORE TO PREDICT MORTALITY IN UPPER GASTROINTESTINAL BLEEDING
COMPARISSION OF THE NEW ABC SCORE AND MAP(ASH) SCORE TO PREDICT MORTALITY IN UPPER GASTROINTESTINAL BLEEDING

Manuel López-Vico  et al.

EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN’S DISEASE PATIENTS WITH INSUFFICIENT RESPONSE TO STANDARD-DOSE SUBCUTANEOUS MAINTENANCE THERAPY: AN OBSERVATIONAL MULTICENTRE STUDY
EFFECTIVENESS OF USTEKINUMAB DOSE ESCALATION IN CROHN’S DISEASE PATIENTS WITH INSUFFICIENT RESPONSE TO STANDARD-DOSE SUBCUTANEOUS MAINTENANCE THERAPY: AN OBSERVATIONAL MULTICENTRE STUDY

Manuel López-Vico  et al.

Item 1 - 9 / 9
1